Molecular Partners AG reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was CHF 7.04 million compared to CHF 189.6 million a year ago. Net loss was CHF 61.98 million compared to net income of CHF 117.85 million a year ago.

Basic loss per share from continuing operations was CHF 1.89 compared to basic earnings per share from continuing operations of CHF 3.63 a year ago. Diluted loss per share from continuing operations was CHF 1.89 compared to diluted earnings per share from continuing operations of CHF 3.54 a year ago.